XML 33 R8.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Operating activities      
Net income $ 432,272 $ 376,401 $ 1,018,477
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 275,953 156,575 141,492
Amortization of deferred financing costs and debt discount 13,099 8,881 7,363
Straight-line rent revenue and other (226,906) (138,806) (100,594)
Share / (Unit)-based compensation expense 47,154 32,188 16,505
Loss (gain) from sale of real estate 2,833 (41,560) (719,392)
Impairment charges 19,006 21,031 48,007
Straight-line rent and other write-off 26,415 22,447 18,002
Debt refinancing and unutilized financing costs 28,180 6,106  
Pre-acquisition rent collected - Circle Transaction (35,020)    
Other adjustments 17,429 (2,271) (3,768)
Changes in:      
Interest and rent receivables (2,438) 12,906 46,498
Other assets 18,264 (4,992) (18,051)
Accounts payable and accrued expenses (18,424) 39,630 (5,596)
Deferred revenue 19,819 5,581 145
Net cash provided by operating activities 617,636 494,117 449,088
Investing activities      
Cash paid for acquisitions and other related investments (4,249,180) (4,565,594) (1,430,995)
Net proceeds from sale of real estate 94,177 111,766 1,513,666
Principal received on loans receivable 1,306,187 920 885,917
Investment in loans receivable (62,651) (54,088) (212,002)
Construction in progress and other (68,350) (83,798) (53,967)
Return of equity investment 69,224    
Capital additions and other investments, net (36,180) (293,163) (138,441)
Net cash (used for) provided by investing activities (2,946,773) (4,883,957) 564,178
Financing activities      
Proceeds from term debt, net of discount 2,215,950 3,048,424 759,735
Payments of term debt (800,000)    
Revolving credit facilities, net 162,633 (65,736) (811,718)
Dividends / Distribution paid (567,969) (411,697) (363,906)
Lease deposits and other obligations to tenants 21,706 (12,260) (20,606)
Proceeds from sale of common shares, net of offering costs 411,101 2,533,210 94,239
Payment of debt refinancing, deferred financing costs and other financing activities (42,347) (50,057) (3,614)
Net cash provided by (used for) financing activities 1,401,074 5,041,884 (345,870)
(Decrease) increase in cash, cash equivalents, and restricted cash for the year (928,063) 652,044 667,396
Effect of exchange rate changes 16,441 (6,478) (17,218)
Cash, cash equivalents, and restricted cash at beginning of year 1,467,991 822,425 172,247
Cash, cash equivalents, and restricted cash at end of year 556,369 1,467,991 822,425
Interest paid, including capitalized interest of $3,030 in 2020, $3,936 in 2019, and $1,480 in 2018 309,920 211,163 221,779
Supplemental schedule of non-cash financing activities:      
Dividends declared, unpaid 147,666 138,161 95,419
Cash, cash equivalents, and restricted cash are comprised of the following:      
Cash and cash equivalents at beginning of period 1,462,286 820,868 171,472
Restricted cash, included in Other assets at beginning of period $ 5,705 $ 1,557 $ 775
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List] us-gaap:OtherAssets us-gaap:OtherAssets us-gaap:OtherAssets
Cash, cash equivalents, and restricted cash at beginning of year $ 1,467,991 $ 822,425 $ 172,247
Cash and cash equivalents at end of period 549,884 1,462,286 820,868
Restricted cash, included in Other assets at end of period 6,485 $ 5,705 $ 1,557
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List]   us-gaap:OtherAssets us-gaap:OtherAssets
Cash, cash equivalents, and restricted cash at end of year 556,369 $ 1,467,991 $ 822,425
MPT Operating Partnership, L.P. [Member]      
Operating activities      
Net income 432,272 376,401 1,018,477
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 275,953 156,575 141,492
Amortization of deferred financing costs and debt discount 13,099 8,881 7,363
Straight-line rent revenue and other (226,906) (138,806) (100,594)
Share / (Unit)-based compensation expense 47,154 32,188 16,505
Loss (gain) from sale of real estate 2,833 (41,560) (719,392)
Impairment charges 19,006 21,031 48,007
Straight-line rent and other write-off 26,415 22,447 18,002
Debt refinancing and unutilized financing costs 28,180 6,106  
Pre-acquisition rent collected - Circle Transaction (35,020)    
Other adjustments 17,429 (2,271) (3,768)
Changes in:      
Interest and rent receivables (2,438) 12,906 46,498
Other assets 18,264 (4,992) (18,051)
Accounts payable and accrued expenses (18,424) 39,630 (5,596)
Deferred revenue 19,819 5,581 145
Net cash provided by operating activities 617,636 494,117 449,088
Investing activities      
Cash paid for acquisitions and other related investments (4,249,180) (4,565,594) (1,430,995)
Net proceeds from sale of real estate 94,177 111,766 1,513,666
Principal received on loans receivable 1,306,187 920 885,917
Investment in loans receivable (62,651) (54,088) (212,002)
Construction in progress and other (68,350) (83,798) (53,967)
Return of equity investment 69,224    
Capital additions and other investments, net (36,180) (293,163) (138,441)
Net cash (used for) provided by investing activities (2,946,773) (4,883,957) 564,178
Financing activities      
Proceeds from term debt, net of discount 2,215,950 3,048,424 759,735
Payments of term debt (800,000)    
Revolving credit facilities, net 162,633 (65,736) (811,718)
Dividends / Distribution paid (567,969) (411,697) (363,906)
Lease deposits and other obligations to tenants 21,706 (12,260) (20,606)
Proceeds from sale of units, net of offering costs 411,101 2,533,210 94,239
Payment of debt refinancing, deferred financing costs and other financing activities (42,347) (50,057) (3,614)
Net cash provided by (used for) financing activities 1,401,074 5,041,884 (345,870)
(Decrease) increase in cash, cash equivalents, and restricted cash for the year (928,063) 652,044 667,396
Effect of exchange rate changes 16,441 (6,478) (17,218)
Cash, cash equivalents, and restricted cash at beginning of year 1,467,991 822,425 172,247
Cash, cash equivalents, and restricted cash at end of year 556,369 1,467,991 822,425
Interest paid, including capitalized interest of $3,030 in 2020, $3,936 in 2019, and $1,480 in 2018 309,920 211,163 221,779
Supplemental schedule of non-cash financing activities:      
Dividends declared, unpaid 147,666 138,161 95,419
Cash, cash equivalents, and restricted cash are comprised of the following:      
Cash and cash equivalents at beginning of period 1,462,286 820,868 171,472
Restricted cash, included in Other assets at beginning of period $ 5,705 $ 1,557 $ 775
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List] us-gaap:OtherAssets us-gaap:OtherAssets us-gaap:OtherAssets
Cash, cash equivalents, and restricted cash at beginning of year $ 1,467,991 $ 822,425 $ 172,247
Cash and cash equivalents at end of period 549,884 1,462,286 820,868
Restricted cash, included in Other assets at end of period $ 6,485 $ 5,705 $ 1,557
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List] us-gaap:OtherAssets us-gaap:OtherAssets us-gaap:OtherAssets
Cash, cash equivalents, and restricted cash at end of year $ 556,369 $ 1,467,991 $ 822,425